Kidivent-LS Oral Drops is a multi-ingredient formulation designed to provide symptomatic relief in pediatric patients suffering from respiratory conditions characterized by cough, bronchospasm, and excessive mucus production. Each milliliter contains Ambroxol 7.5 mg, Levosalbutamol 0.25 mg, and Guaifenesin 12.5 mg. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscles, reducing airway resistance, and alleviating bronchospasm. Guaifenesin serves as an expectorant, enhancing the hydration of respiratory secretions and promoting their expectoration. The combination of these active ingredients makes Kidivent-LS Oral Drops effective in managing conditions such as bronchitis, asthma exacerbations, and other obstructive airway diseases in children. The oral drop formulation allows for precise dosing and ease of administration in pediatric patients. It is recommended to use this medication under medical supervision, adhering strictly to prescribed dosages to minimize potential side effects such as tachycardia, tremors, or gastrointestinal discomfort. Kidivent-LS Oral Drops should be avoided in patients with hypersensitivity to any component or with certain cardiovascular disorders.